AIEU-Startupsabout 3 hours ago
Houdini Bio exits stealth with €1.7M for gene therapies
4 min read
Houdini Bio exited stealth with €1.7 million in pre-Seed funding led by SCVC. The British biotech startup's platform designs DNA sequences to overcome biological barriers in genetic medicines. The funding allowed the company to validate its technology and hit technical milestones in a third of the predicted time.
Level
Hype check
Tap to vote and see what everyone thinks.
